Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
B cell receptor signaling pathway | R-HSA-983705 | map04662 | loperamide | 3955 | drug-path |
Wnt signaling pathway | R-HSA-195721 | map04310 | loperamide | 3955 | drug-path |
Axon guidance | R-HSA-422475 | map04360 | loperamide | 3955 | drug-path |
Apoptosis | R-HSA-109581 | map04210 | loperamide | 3955 | drug-path |
VEGF signaling pathway | R-HSA-194138 | map04370 | loperamide | 3955 | drug-path |
MAPK signaling pathway | R-HSA-9652817 | map04010 | loperamide | 3955 | drug-path |
Gap junction | R-HSA-190861 | map04540 | loperamide | 3955 | drug-path |
Calcium signaling pathway | R-HSA-381753 | map04020 | loperamide | 3955 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | diltiazem | 39186 | drug-path |
B cell receptor signaling pathway | R-HSA-983705 | map04662 | diltiazem | 39186 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | hesperetin | 4030 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | hesperetin | 4030 | drug-path |
VEGF signaling pathway | R-HSA-194138 | map04370 | hesperetin | 4030 | drug-path |
Jak-STAT signaling pathway | R-HSA-168638 | map04630 | hesperetin | 4030 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | hesperetin | 4030 | drug-path |
Calcium signaling pathway | R-HSA-381753 | map04020 | hesperetin | 4030 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | ampicillin | 239 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | ampicillin | 239 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | ampicillin | 239 | drug-path |
Toll-like receptor signaling pathway | R-HSA-168898 | map04620 | ampicillin | 239 | drug-path |